Abstract
D&MD' s Guide to Business Plan Writing, 3rd edition helps companies in the life
sciences industry create an effective business plan for early and mid-stage
stage business ventures. Businesses in the life science industry, which
includes biotechnology, agricultural technology, pharmaceutical products,
health services and medical devices, face similar hurdles in the development
of their businesses. These challenges are often distinct from what is faced in
other non-life science based industries.
Table of Contents
Chapter 1: Executive Summary
Chapter 2: Introduction
- The Purpose of a Business Plan
- The Purpose of This Guide
Chapter 3: Planning the Business
- Introduction
- The Product or Service
- The Market
- The Competition
- The Intellectual Property
- The Regulatory Environment
- The Strategy
- Research and Development
- Production
- Market Entry
- The Team
- The Corporate Structure
- The Operations
- The Financials
- The Simplicity
- The Iteration
- Additional Considerations
Chapter 4: Writing the Plan
- Your Audience
- The Thesis Statements
- The Support
- The Execution
- Section 3: Writing the Plan
- Responsibilities of the Writer
- Introduction to the Template
- Executive Summary
- An Overview of the Company
- Market
- Description
- Size and Growth Rates
- Trends
- Unmet Needs
- Rate of Adoption
- Pricing
- Potential Share of Your Product or Service
- The Technology
- Current Status
- Matching the Technology with the Market
- Future Development
- The Intellectual Property (IP)
- Freedom to Operate
- Current IP
- Future IP
- The Regulatory Environment (If Applicable)
- The Competition
- The Strategy
- Research and Development
- Commercialization
- Marketing
- The Timelines
- The Operations
- The Team
- Current Team and Why It Is Capable
- Future Hires
- Risks
- Financials
- Financing Strategy
- Historical Financials
- Projections
- Exit Strategy
- The Investment Opportunity
- The Appendices
- Additional Market Information
- Detailed Technical Information
- Financial Documents
- Biographies of Team Members
- Additional Information
Appendix 1: Sample Business Plan
Appendix 2: Example Financial Statements and Notes to the Financial Statements
Appendix 3: Example Pro forma Financial Statements for a Drug Development Company over 2 years by Quarter
Table of Exhibits
- Exhibit 3.1 Example of a Top-Down Model (In $ millions)
- Exhibit 3.2 Example of a Bottom-Up Model (In $ millions)
- Exhibit 3.3 Additional Examples of Bottom-Up Models
- Exhibit 3.4 Examples of Incorporating Growth Rates (In $ millions)
- Exhibit 4.1 Your Audiences
- Exhibit 4.2 Representative Comparative Analysis
- Exhibit 4.3 Representative Gantt Chart for Technology Development
|